Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Ambulance iPads Improve Patient Care Under NHS Long Term Plan
Tens of thousands of iPads will be issued to ambulance crews across England so that […]
Medicago and GSK Announce Positive Interim Phase 2 Results for Adjuvanted Covid-19 Vaccine Candidate
Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) are pleased to report […]
Novo Holdings Leads Series C in Hummingbird
Novo Holdings today announced that it has led the oversubscribed US$125 million Series C financing in Hummingbird […]
Pharmacy Quality Solutions (PQS) Welcomes Todd Sega as New CEO
Pharmacy Quality Solutions (PQS), a leading technology provider of pharmacy performance management services, announced today […]
NovAliX Expands Cryo-electron Microscopy (Cryo-EM) Capabilities for Drug Development Offering
NovAliX, a drug discovery-focused Contract Research Organization (CRO), today announces the expansion of its cryogenic […]
AELIX Therapeutics Appoints Dr Melanie Rolli as CEO
AELIX Therapeutics S.L. (‘AELIX’), a clinical-stage biotechnology company specialized in the discovery and development of […]
Sanofi and GSK COVID-19 Vaccine Candidate Demonstrates Strong Immune Responses Across All Adult Age Groups in Phase 2 Trial
The Sanofi and GSK adjuvanted recombinant COVID-19 vaccine candidate achieved strong rates of neutralizing antibody […]
BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics Enter Strategic R&D Alliance
BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, FUJIFILM […]
Bayer Invites Young Leaders to Apply for 5th Biennial Youth Ag Summit
Applications are now open for the 2021 Youth Ag Summit, a global forum and biennially organized […]
New Measures to Boost Response to B1.617.2 Variant
The B1.617.2 variant of concern is beginning to spread increasingly rapidly in certain areas across […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more